Solid Tumor Market By Tumor Type (Benign Solid Tumors, Malignant Solid Tumors), By Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Liver Cancer, Pancreatic Cancer, Kidney Cancer, Others), By Treatment Type (Chemotherapy, Targeted Therapy, Immunotherapy, Hormone Therapy, Gene Therapy, Combination Therapy, Others), By End-user (Hospitals, Cancer Research Institutes, Clinics, Ambulatory Surgical Centers), Global Market Size, Segmental Analysis, Regional Overview, Company Share Analysis, Leading Company Profiles, and Market Forecast, 2025 – 2035.
Published Date: Mar 2025 | Report ID: MI2349 | 220 Pages
Report Coverage:
By Tumor Type
- Benign solid tumors
- Malignant solid tumors
By Cancer Type
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Prostate Cancer
- Liver Cancer
- Pancreatic Cancer
- Kidney Cancer
- Others
By Treatment Type
- Chemotherapy
- Targeted Therapy
- Immunotherapy
- Hormone Therapy
- Gene Therapy
- Combination Therapy
- Others
By End-user
- Hospitals
- Cancer Research Institutes
- Clinics
- Ambulatory Surgical Centers
- Others
By Region
North America
- U.S.
- Canada
Europe
- U.K.
- France
- Germany
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Singapore
- Rest of Asia Pacific
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East & Africa
List of Companies:
- Roche Holding AG
- Pfizer Inc.
- Bristol Myers Squibb
- Merck & Co., Inc.
- Eli Lilly and Company
- AstraZeneca PLC
- Novartis AG
- Johnson & Johnson
- Amgen Inc.
- Sanofi S.A.
- AbbVie Inc.
- Bayer AG
- GlaxoSmithKline plc
- Regeneron Pharmaceuticals, Inc.
- Baxter International Inc.
Maximize your value and knowledge with our 5 Reports-in-1 Bundle - over 40% off!
Our analysts are ready to help you immediately.